Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: Correlation with histotype and histological grade

Oncology Reports

Volumn 24, Issue 2, 2010, Pages 305-310

  Barresi, Valeria ^a   Ieni, Antonio ^a   Bolignano, Davide ^a   Magno, Carlo ^a   Buemi, Michele ^a   Barresi, Gaetano ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Fuhrman grade; Iron; Neutrophil gelatinase associated lipocalin; Renal tumors

Indexed keywords

CHELATING AGENT; GELATINASE; LIPOCALIN; ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; ONCOPROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER THERAPY; CARCINOGENESIS; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; ENZYME SYNTHESIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRON TRANSPORT; KIDNEY CARCINOMA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE; KIDNEY TUMOR; MALE; NEOPLASM; NEUTROPHIL; ONCOCYTOMA; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; CANCER STAGING; CARCINOMA, RENAL CELL; CLASSIFICATION; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; PERITONEUM TUMOR; PHENOTYPE; PROCEDURES; SECONDARY; VERY ELDERLY;

ACUTE-PHASE PROTEINS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; LIPOCALINS; MALE; MIDDLE AGED; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PHENOTYPE; PROTO-ONCOGENE PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954365854     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000860     Document Type: Article

References (41)

1. Cowland JB and Borregaard N: Molecular charcterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45: 17-23, 1997.
2. Bratt T: Lipocalins and cancer. Biochim Biophys Acta 1482: 318-326, 2000.
3. Yang J, Goetz D, Li JY, Wang W, Mori K and Setlik D: An iron delivery pathway mediated by a lipocalin. Mol Cell 10: 1045-1056, 2002.
4. Goetz DH, Willie ST, Arme RS, Bratt T, Borregaard N and Strong RK: Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry 39: 1935-1941, 2000.
5. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN and Strong RK: The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10: 1033-1043, 2002.
6. Mori K, Yang J and Barasch J: Ureteric bud controls multiple steps in the conversion of mesenchyme to epithelia. Semin Cell Dev Biol 14: 209-216, 2003.
7. Gwira JA, Wei F and Ishibe S: Expression of neutrophil associated-gelatinase lipocalin regulates epithelial morphogenesis in vitro. J Biol Chem 280: 7875-7882, 2005.
8. Stoesz SP and Gould MN: Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas. Oncogene 11: 2233-2241, 1995.
9. Hannai J, Mammoto T, Seth P, et al: Lipocalin2 diminishes invasiveness and metastasis of Ras-transformed cells. J Biol Chem 280: 3641-3647, 2005.
10. Bolignano D, Donato V, Lacquaniti A, et al: Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. Cancer Lett (In press).
11. Devireddy LR, Gazin C, Zhu X and Green MR: A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 23: 1293-1305, 2005. (Pubitemid 41821786)
12. Iannetti A, Pacifico F, Acquaviva R, et al: The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci USA 105: 14058-14063, 2008.
13. Yan L, Borregaard N, Kjeldsen L and Moses MA: The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 276: 37258-37265, 2001.
14. Fernandez CA, Yan L, Louis G, et al: The matrix metalloproteinase-9/ nuetrophil gelatinase associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 11: 5390-5395, 2005.
15. Lee S, Jilani SM, Nikolova GV, Carpizo D and Iruela-Arispe ML: Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 169: 681-691, 2005.
16. Devarajan P: Neutrophil gelatinase-associated lipocalin: new paths for an old shuttle. Cancer Ther 5: 463-470, 2007.
17. Stoesz SP, Friedl A, Haag JD, Lindstrom MJ, Clark GM and Gould MN: Heterogeneous expression of the lipocalin NGAL in primary breast cancer. Breast Cancer Res Treat 79: 565-572, 1998.
18. Bauer M, Eickhoff JC, Gould MN, Mundhenke C, Maas N and Friedl A: Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat 108: 389-397, 2008.
19. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M and Kjeldsen L: Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38: 414-420, 1996. (Pubitemid 126423216)
20. Zhang XF, Zhang Y, Zhang XH, et al: Clinical significance of Neutrophil gelatinase-associated lipocalin (NGAL) expression in primary rectal cencer. BMC Cancer 9: 134, 2009.
21. Kubben FJ, Sier CF, Hawinkels LJ, et al: Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Eur J Cancer 43: 1869-1876, 2007.
22. Zhang H, Xu L, Xiao D, et al: Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J Clin Pathol 60: 555-561, 2007.
23. Laurell H, Bouisson M, Berthelemy P, et al: Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. World J Gastroenterol 12: 3344-3351, 2006.
24. Friedl A, Stoesz SP, Buckley P and Gould MN: Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J 31: 433-441, 1999.
25. Bolignano D, Coppolino G, Lacquaniti A, Nicocia G and Buemi M: Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin (NGAL) in macroproteinuric patients with worsening renal function. Kidney Blood Press Res 31: 274-279, 2008.
26. Bolignano D, Lacquaniti A, Coppolino G, et al: Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 4: 337-344, 2009.
27. Kovacs G, Akhtar M, Beckwith BJ, et al: The Heidelberg classification of renal cell tumours. J Pathol 183: 131-133, 1997.
28. Fuhrman SA, Lasky LC and Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma Am J Surg Pathol 6: 655-633, 1982.
29. Guinan P, Sobin LH, Algaba F, et al: TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80: 992-993, 1997.
30. Devarajan P, Mishra J, Supavekin S, Patterson LT and Potter S: Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab 80: 365-376, 2003.
31. Moniaux N, Chakraborty S, Yalniz M, et al: Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer 98: 1540-1547, 2008.
32. Bolignano D, Donato V, Coppolino G, et al: Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 52: 595-605, 2008.
33. Szponar A, Zubakov D, Pawlak J, Jauch A and Kovacs G: Three genetic developmental stages of papillary renal cell tumors: duplication of chromosome 1q marks fatal progression. Int J Cancer 124: 2071-2076, 2009.
34. Yang J, Mori K, Li JY and Barasch J: Iron, lipocalin and kidney epithelia. Am J Physiol Renal Physiol 285: F9-F18, 2003.
35. Giuffrè G, Barresi V, Skliros C, Barresi G and Tuccari G: Immunoexpression of lactoferrin in human sporadic renal cell carcinomas. Oncol Rep 17: 1021-1026, 2007.
36. Loughlin KR, Gittes RF, Partridge D and Stelos P: The relationship of lactoferrin to the anemia of renal cell carcinoma. Cancer 59: 566-571, 1987.
37. Liu M and Okada S: Induction of free radicals and tumors in kidneys of Wistar rats by ferric ethylenediamine-N,N-diacetate. Carcinogenesis 15: 2817-2821, 1994.
38. Toyokuni S: Role of iron in carcinogenesis: Cancer as a ferrotoxic disease. Cancer Sci 100: 9-16, 2009.
39. Le NT and Richardson DR: The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta 1603: 31-46, 2002.
40. Lim R, Ahmed N, Borregaard N, et al: Neutrophil gelatinase-associated lipocalin (NGAL) an early screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer 120: 2426-2434, 2007. (Pubitemid 46642130)
41. Smith ER, Zurakowski D, Saad A, Scott RM and Moses MA: Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res 14: 2378-2386, 2008.